biogen

Page 2 of 4

Capsule-Booster Shots
Newsletters

Why the FDA’s ruling on mixing and matching vaccines will help more people get boosters

By
October 21, 2021
The stalemate over patents is fueling vaccine inequity—and the pandemic
Newsletters

The stalemate over patents is fueling vaccine inequity—and the pandemic

By
October 14, 2021
Merck-Antiviral Pill
Newsletters

Why Merck’s antiviral pill is not a silver bullet for COVID

By
October 7, 2021
Workspace-Vaccine Mandate-healthcare shortage
Newsletters

Will vaccine mandates worsen the ongoing health care shortage?

By
September 30, 2021
The science of a farewell
Newsletters

The science behind a fond farewell

By
September 23, 2021
CDC masking indoor businesses Apple
Newsletters

Offices, employees, and customers: The COVID mask conundrum

By
July 29, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
Newsletters

The never ending Biogen Alzheimer’s drug saga delivers yet another twist

By
July 8, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
Health

Biogen makes a drastic move, as doctors refuse to prescribe its controversial Alzheimer’s drug

By
July 8, 2021
Janet Woodcock, acting commissioner of the U.S. Food and Drug Administration (FDA), listens during a Senate Appropriations Subcommittee hearing in Washington, D.C., U.S., on Thursday, June 10, 2021. The hearing is titled "Fiscal Year 2022 Budget Request for the FDA." Photographer: Al Drago/Bloomberg via Getty Images
Health

Pressure mounts on Biden to nominate permanent FDA head as dissatisfaction with agency grows

By
June 22, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
Health

Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?

By
June 9, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
Health

FDA approves Biogen’s controversial Alzheimer’s drug in historic decision

By
June 7, 2021
FDA Biogen Alzheimer's Janet Woodcock
Health

President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals

By
May 25, 2021
Drug price hikes big pharma 2021
Health

It’s the New Year, and pharma companies are already hiking prices for popular drugs

By
January 4, 2021
OneUnited Bank CEO Kevin Cohee
Finance

Biogen moves $10 million to Black-owned OneUnited, joining the Fortune 500 trend to ‘Bank Black’

By
September 3, 2020
George Scangos coronavirus czar biotech
Newsletters

Pharma vet and former Biogen chief to lead biotech industry’s coronavirus response

By
March 2, 2020

Most Popular